Keele Research Repository

Article

Glynn, D, Bliss, J, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Coles, CE, Wheatley, D, Haviland, JS, Kirby, AM, Longo, F, Faria, R, Yarnold, JR and Griffin, S (2022) Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis. Breast Cancer Research and Treatment. 1 - 12.

Meattini, I, Becherini, C, Boersma, L, Kaidar-Person, O, Marta, GN, Montero, A, Offersen, BV, Aznar, MC, Belka, C, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Dicuonzo, S, Franco, P, Krause, M, MacKenzie, M, Marinko, T, Marrazzo, L, Ratosa, I, Scholten, A, Senkus, E, Stobart, H, Poortmans, P and Coles, CE (2022) European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncology, 23 (1). e21 - e31.

Obeng-Gyasi, S, Coles, CE, Jones, J, Sacks, R, Lightowlers, S, Bliss, JM, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Kirby, AM and Kalinsky, K (2021) When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management. American Society of Clinical Oncology educational book, 41. 1 - 11.

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, CE, Emson, M, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, C, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Wilcox, M, Bliss, JM and Yarnold, JR (2020) FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results. Radiotherapy and Oncology, 152 (S1). S346 - S347.

Coles, CE, Aristei, C, Bliss, J, Boersma, L, Brunt, AM, Chatterjee, S, Hanna, G, Jagsi, R, Kaidar Person, O, Kirby, A, Mjaaland, I, Meattini, I, Luis, AM, Marta, GN, Offersen, B, Poortmans, P and Rivera, S (2020) International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic. Clinical Oncology, 32 (5). 279 - 281.

Brunt, AM, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, DJ, Chan, C, Churn, M, Cleator, S, Coles, CE, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, CC, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Bliss, JM, Yarnold, JR and FAST-Forward Trial Management Group, . (2020) Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet, 395 (10237). 1613 - 1626.

Coles, CE, Griffin, CL, Kirby, AM, Haviland, JS, Titley, JC, Benstead, K, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Chan, C, Ciurlionis, L, Din, OS, Donovan, EM, Eaton, DJ, Harnett, AN, Hopwood, P, Jefford, ML, Jenkins, PJ, Lee, CE, McCormack, M, Sherwin, L, Syndikus, I, Tsang, Y, Twyman, NI, Ventikaraman, R, Wickers, S, Wilcox, MH, Bliss, JM and Yarnold, JR (2019) Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003). Cancer Research, 79 (4).

Coles, CE, Griffin, CL, Kirby, AM, Titley, J, Agrawal, RK, Alhasso, A, Bhattacharya, IS, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Ciurlionis, L, Chan, C, Donovan, EM, Emson, MA, Harnett, AN, Haviland, JS, Hopwood, P, Jefford, ML, Kaggwa, R, Sawyer, EJ, Syndikus, I, Tsang, YM, Wheatley, DA, Wilcox, M, Yarnold, JR, Bliss, JM and Trialists, IMPORT (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet, 390 (10099). 1048 - 1060.